|Videos|April 16, 2020
Modernizing Drug Development in the Face of the COVID-19 Pandemic
Author(s)Cognizant
Advertisement
Drug development paradigms need to change in order to quickly bring new therapeutics to patients affected by pandemics like COVID-19.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5